-+ 0.00%
-+ 0.00%
-+ 0.00%

Mirum Pharma Shares Gain After Liver-Disease Treatment Meets Primary Endpoint in Phase 3 Trial

Dow Jones·10/12/2026 13:17:00

Please log in to view news